[{"address1": "1111 Kane Concourse", "address2": "Suite 301", "city": "Bay Harbor Islands", "state": "FL", "zip": "33154", "country": "United States", "phone": "781 652 4500", "website": "https://www.avenuetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alexandra  MacLean M.D.", "age": 57, "title": "CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 413200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Jin", "age": 33, "title": "Interim CFO, COO & Corporate Secretary", "yearBorn": 1991, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald", "age": 69, "title": "Executive Director", "yearBorn": 1955, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott A. Reines M.D., Ph.D.", "age": 77, "title": "Interim Chief Medical Officer", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 69120, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.36, "open": 1.36, "dayLow": 1.3301, "dayHigh": 1.3897, "regularMarketPreviousClose": 1.36, "regularMarketOpen": 1.36, "regularMarketDayLow": 1.3301, "regularMarketDayHigh": 1.3897, "beta": -0.288, "trailingPE": 0.05488297, "forwardPE": -0.433121, "volume": 103665, "regularMarketVolume": 103665, "averageVolume": 400433, "averageVolume10days": 79350, "averageDailyVolume10Day": 79350, "bid": 1.35, "ask": 1.37, "bidSize": 100, "askSize": 100, "marketCap": 2793331, "fiftyTwoWeekLow": 1.22, "fiftyTwoWeekHigh": 15.0, "fiftyDayAverage": 1.7117, "twoHundredDayAverage": 2.623985, "currency": "USD", "enterpriseValue": -955179, "floatShares": 1479260, "sharesOutstanding": 2053920, "sharesShort": 154915, "sharesShortPriorMonth": 22479, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0754, "heldPercentInsiders": 0.25225002, "heldPercentInstitutions": 0.10077, "shortRatio": 0.15, "shortPercentOfFloat": 0.0754, "impliedSharesOutstanding": 2131720, "bookValue": 1.627, "priceToBook": 0.8358943, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -18278000, "trailingEps": 24.78, "forwardEps": -3.14, "lastSplitFactor": "1:75", "lastSplitDate": 1714089600, "52WeekChange": -0.8782998, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ATXI", "underlyingSymbol": "ATXI", "shortName": "Avenue Therapeutics, Inc.", "longName": "Avenue Therapeutics, Inc.", "firstTradeDateEpochUtc": 1498570200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ab3c15b5-e280-3b5c-b842-8e87c6276492", "messageBoardId": "finmb_310815442", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.36, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 2597000, "totalCashPerShare": 1.359, "quickRatio": 2.669, "currentRatio": 2.698, "returnOnAssets": -4.71938, "freeCashflow": -10095750, "operatingCashflow": -10586000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]